Principaux concurrents
Rendement du dividende (Y) Rendement du dividende (Y+1) PER (Y) Price to Book (Y) VE / CA (Y) VE / EBITDA (Y) VE / EBIT (Y) Capi.($)
- - - - - - - 5,52 Md
0,59 %0,68 %17.24x1.96x3.71x9.75x11.08x 66,75 Md
0,63 %0,65 %25.12x3.77x5.15x15.13x18.87x 50,65 Md
-.--%-.--%33.84x6.8x11.49x21.95x25.58x 42,55 Md
3,32 %3,4 %-46.25x2.52x3.25x9.6x11.2x 41,15 Md
-.--%-.--%33.28x1.52x3.36x11.24x12.81x 28,34 Md
-.--%-.--%-7.78x4.72x11.15x-6.85x-6.43x 26,76 Md
-.--%-.--%33.67x - - - - 22,95 Md
-.--%0,05 %62.3x5.76x6.33x43.55x42.67x 20 Md
-.--%-.--%-38.32x-6.71x17.89x-54.31x-56.78x 16,48 Md
-.--%-.--%25.21x3.54x5.21x13.96x19.24x 16,3 Md
-.--%-.--%-114.41x12460.81x12.23x-87.73x-120.46x 12,11 Md
-.--%-.--%16.65x - 3.55x13.02x15.6x 11,33 Md
0,18 %0,19 %51.14x20.85x30.87x43.66x45.03x 10,06 Md
-.--%-.--%44.79x - - - - 10,01 Md
0,34 %0,4 %30.13x - 8.14x21.59x25.78x 6,15 Md
2,89 %3,34 %11.62x1.01x1.79x7.22x9.68x 6,1 Md
1,63 %1,81 %13.8x1.27x2.39x6.2x7.51x 5,55 Md
Moyenne 0,56 % 0,62 % 11,30x 962,14x 8,43x 4,53x 4,09x 22,15 Md
Moyenne pondérée par Capi. 0,61 % 0,65 % 11,68x 443,49x 7,23x 7,83x 8,60x
Biopharmacies
🔇